Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

AtriCure (ATRC) Return on Sales (2016 - 2025)

AtriCure (ATRC) has disclosed Return on Sales for 16 consecutive years, with 0.01% as the latest value for Q4 2025.

  • Quarterly Return on Sales rose 14.0% to 0.01% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.02% through Dec 2025, up 7.0% year-over-year, with the annual reading at 0.02% for FY2025, 7.0% up from the prior year.
  • Return on Sales for Q4 2025 was 0.01% at AtriCure, up from 0.0% in the prior quarter.
  • The five-year high for Return on Sales was 1.38% in Q3 2021, with the low at 0.29% in Q1 2021.
  • Average Return on Sales over 5 years is 0.03%, with a median of 0.08% recorded in 2023.
  • The sharpest move saw Return on Sales soared 147bps in 2021, then tumbled -153bps in 2022.
  • Over 5 years, Return on Sales stood at 0.19% in 2021, then surged by 75bps to 0.05% in 2022, then tumbled by -94bps to 0.09% in 2023, then tumbled by -36bps to 0.13% in 2024, then soared by 110bps to 0.01% in 2025.
  • According to Business Quant data, Return on Sales over the past three periods came in at 0.01%, 0.0%, and 0.05% for Q4 2025, Q3 2025, and Q2 2025 respectively.